Is there any association of apolipoprotein E gene polymorphisms with metabolic syndrome in a young population of Croatian origin?

References

• Alberti K, Zimmet P, Shaw J. 2005. The metabolic syndrome – a new worldwide definition. Lancet 366:1059–1062.
   PubMed Web of Science ®Google Scholar
• Alvim RO, Freitas SRS, Ferreira NE, Santos PCJL, Cunha RS, Mill JG, et al. 2010. APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population. Lipids Health Dis 9:128.
   PubMedGoogle Scholar
• Andreassi MG. 2009. Metabolic syndrome, diabetes and atherosclerosis: Influence of gene-environment interaction. Mutat Res-Fund Mol M 667:35–43.
   PubMed Web of Science ®Google Scholar
• Babio N, Bullo M, Basora J, Martinez-Gonzalez MA, Fernandez-Ballart J, Marquez-Sandoval F, et al. 2009. Adherence to the Mediterranean diet and risk of metabolic syndrome and its components. Nutr Metab Cardiovas 19:563–570.
   Web of Science ®Google Scholar
• Balwierz A, Polus A, Razny U, Wator L, Dyduch G, Tomaszewska R, et al. 2009. Angiogenesis in the New Zealand obese mouse model fed with high fat diet. Lipids Health Dis 8:13.
   PubMed Web of Science ®Google Scholar
• Boer JM, Ehnholm C, Menzel HJ, Havekes LM, Rosseneu M, O'Reilly DS, Tiret L. 1997. Interactions between lifestyle-related factors and the ApoE polymorphism on plasma lipids and apolipoproteins. The EARS Study. European Atherosclerosis Research Study. Arterioscler Thromb Vasc Biol 17:1675–1681.
   PubMed Web of Science ®Google Scholar
• Bu GJ. 2009. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10:333–344.
   PubMed Web of Science ®Google Scholar
• Camargo A, Meneses ME, Perez-Martinez P, Delgado-Lista J, Rangel-Zuniga OA, Marin C, et al. 2014. Dietary fat modifies lipid metabolism in the adipose tissue of metabolic syndrome patients. Genes Nutr 9:409. doi:10.1007/s12263-014-0409-3.
   PubMed Web of Science ®Google Scholar
• Carmel JF, Tarnus E, Cohn JS, Bourdon E, Davignon J, Bernier L. 2009. High expression of Apolipoprotein E impairs lipid storage and promotes cell proliferation in human adipocytes. J Cell Biochem 106:608–617.
   PubMed Web of Science ®Google Scholar
• Chiba T, Nakazawa T, Yui K, Kaneko E, Shimokado K. 2003. VLDL induces adipocyte differentiation in ApoE-dependent manner. Arterioscl Throm Vas 23:1423–1429.
   Google Scholar
• Cho S-W, Kang J-Y, Park Y-K, Paek Y-M, Choi T-I. 2009. A 12-week worksite health promotion program reduces cardiovascular risk factors in male workers with the apolipoprotein E2 and apolipoprotein E3 genotypes, but not in apolipoprotein E4 genotype. Nutr Res 29:542–550.
   PubMed Web of Science ®Google Scholar
• Dallongeville J, Lussiercacan S, Davignon J. 1992. Modulation of plasma triglyceride levels by apoe phenotype – a metaanalysis. J Lipid Res 33:447–454.
   PubMed Web of Science ®Google Scholar
• Das UN, Puskas LG. 2009. Transgenic fat-1 mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders. Lipids Health Dis 8:61.
   PubMedGoogle Scholar
• De Luis DA, Castrillon JLP, Duenas A. 2009. Leptin and obesity. Minerva Med 100:229–236.
   PubMed Web of Science ®Google Scholar
• Deka R, Durakovic Z, Niu W, Zhang G, Karns R, Smolej-Narancic N, et al. 2012. Prevalence of metabolic syndrome and related metabolic traits in an island population of the Adriatic. Ann Hum Biol 39:46–53.
   PubMed Web of Science ®Google Scholar
• DePaoli AM. 2014. Leptin in common obesity and associated disorders of metabolism. J Endocrinol 223:T71–T81.
   Google Scholar
• Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115–121.
   PubMed Web of Science ®Google Scholar
• Eckel RH, Alberti KGMM, Grundy SM, Zimmet PZ. 2010. The metabolic syndrome. Lancet 375:181–183.
   PubMed Web of Science ®Google Scholar
• Eisenberg DTA, Kuzawa CW, Hayes MG. 2010. Worldwide Allele Frequencies of the Human Apolipoprotein E Gene: climate, local adaptations, and evolutionary history. Am J Phys Anthropol 143:100–111.
   PubMed Web of Science ®Google Scholar
• Excoffier L, Laval G, Schneider S. 2005. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evolut Bioinformat Online 1:47–50.
   PubMed Web of Science ®Google Scholar
• Ferreira DC, Costa TF, Aguiar SLF, Marques ARS, Ramos SA, Gomes KB, Alvarez-Leite JI. 2011. Association of Apoliprotein E polymorphisms and metabolic syndrome in subjects with extreme obesity. Clin Chim Acta 412:1559–1562.
   PubMed Web of Science ®Google Scholar
• Gao JH, Katagiri H, Ishigaki Y, Yamada T, Ogihara T, Imai J, et al. 2007. Involvement of apolipoprotein E in excess fat accumulation and insulin resistance. Diabetes 56:24–33.
   PubMed Web of Science ®Google Scholar
• Gotsis E, Anagnostis P, Mariolis A, Vlachou A, Katsiki N, Karagiannis A. 2015. Health benefits of the mediterranean diet: an update of research over the last 5 years. Angiology 66:304–318.
   PubMed Web of Science ®Google Scholar
• Grundy SM. 2006. Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nat Rev Drug Discov 5:294–309.
   Web of Science ®Google Scholar
• Grundy SM, Neeland IJ, Turer AT, Vega GL. 2014. Ethnic and gender susceptibility to metabolic risk. Metab Syndr Relat D 12:110–116.
   PubMed Web of Science ®Google Scholar
• Guo SW, Thompson EA. 1992. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48:361–372.
   PubMed Web of Science ®Google Scholar
• Huang ZH, Espiritu DJ, Uy A, Holterman AX, Vitello J, Mazzone T. 2011. Adipose tissue depot-specific differences in adipocyte apolipoprotein E expression. Metabolism 60:1692–1701.
   PubMed Web of Science ®Google Scholar
• Huang ZH, Gu D, Mazzone T. 2009. Role of adipocyte-derived apoE in modulating adipocyte size, lipid metabolism, and gene expression in vivo. Am J Physiol Endocrinol Metab 296:E1110–1119.
   Google Scholar
• Huang ZH, Luque RM, Kineman RD, Mazzone T. 2007. Nutritional regulation of adipose tissue apolipoprotein E expression. Am J Physiol Endocrinol Metab 293:E203–209.
   Google Scholar
• Huang ZH, Reardon CA, Mazzone T. 2006. Endogenous ApoE expression modulates adipocyte triglyceride content and turnover. Diabetes 55:3394–3402.
   PubMed Web of Science ®Google Scholar
• Hwang YC, Hayashi T, Fujimoto WY, Kahn SE, Leonetti DL, McNeely MJ, Boyko EJ. 2015. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype. Int J Obesity 39:1365–1370.
   PubMed Web of Science ®Google Scholar
• Karmelic I, Lovric J, Bozina T, Ljubic H, Vogrinc Z, Bozina N, Sertic J. 2012. Adiponectin level and gene variability are obesity and metabolic syndrome markers in a young population. Arch Med Res 43:145–153.
   PubMed Web of Science ®Google Scholar
• Kaur J. 2014. A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014:943162.
   PubMedGoogle Scholar
• Khunti K, Davies M. 2005. Metabolic syndrome - Independently raises cardiovascular risk and should be picked up in primary care. BMJ 331:1153–1154.
   PubMedGoogle Scholar
• Koch W, Hoppmann P, Schomig A, Kastrati A. 2008. Apolipoprotein E gene epsilon 2/epsilon 3/epsilon 4 polymorphism and myocardial infarction: case-control study in a large population sample. Int J Cardiol 125:116–117.
   PubMed Web of Science ®Google Scholar
• Kolcic I, Polasek O,Vuletic S. 2010. Scale and dynamics of overweight and obesity epidemic in croatia. Obesity facts. 3: 333.
   PubMed Web of Science ®Google Scholar
• Kypreos KE. 2009. Mechanisms of obesity and related pathologies. Febs J 276:5719–5719.
   PubMed Web of Science ®Google Scholar
• Kypreos KE, Karagiannides I, Fotiadou EH, Karavia EA, Brinkmeier MS, Giakoumi SM, Tsompanidi EM. 2009. Mechanisms of obesity and related pathologies: role of apolipoprotein E in the development of obesity. Febs J 276:5720–5728.
   PubMed Web of Science ®Google Scholar
• Lai LYH, Petrone AB, Pankow JS, Arnett DK, North KE, Ellison RC, et al. 2015. Lack of association of apolipoprotein E (Apo E) polymorphism with the prevalence of metabolic syndrome: the National Heart, Lung and Blood Institute Family Heart Study. Diabetes-Metab Res 31:582–587.
   PubMed Web of Science ®Google Scholar
• Lasrich D, Bartelt A, Grewal T, Heeren J. 2015. Apolipoprotein E promotes lipid accumulation and differentiation in human adipocytes. Exp Cell Res 337:94–102.
   PubMed Web of Science ®Google Scholar
• Li XT, Du YM, Du YF, Huang XH. 2003. Association of apolipoprotein E gene polymorphism with essential hypertension and its complications. Clin Exp Med 2:175–179.
   PubMed Web of Science ®Google Scholar
• Loos RJF. 2012. Genetic determinants of common obesity and their value in prediction. Best Pract Res Cl En 26:211–226.
   PubMed Web of Science ®Google Scholar
• Luptakova L, Sivakova D, Cvicelova M, Wsolova L, Dankova Z, Michnova A, Blazicek P. 2013. Power of biomarkers and their relative contributions to metabolic syndrome in Slovak adult women. Ann Hum Biol 40:132–138.
   PubMed Web of Science ®Google Scholar
• Ma SJ, Xu SZ. 2015. Semiparametric nonlinear regression for detecting gene and environment interactions. J Stat Plan Infer 156:31–47.
   Web of Science ®Google Scholar
• Matsuzawa Y. 2006. The metabolic syndrome and adipocytokines. Febs Lett 580:2917–2921.
   PubMed Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215–1215.
   Google Scholar
• Moreno JA, Perez-Jimenez F, Marin C, Gomez P, Perez-Martinez P, Moreno R, et al. 2004. The effect of dietary fat on LDL size is influenced by apolipoprotein E genotype in healthy subjects. J Nutr 134:2517–2522.
   PubMed Web of Science ®Google Scholar
• Murdoch SJ, Boright AP, Paterson AD, Zinman B, Steffes M, Cleary P, et al. 2007. LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes. Atherosclerosis 192:138–147.
   PubMed Web of Science ®Google Scholar
• Nauck M, Hoffmann MM, Wieland H, Marz W. 2000. Evaluation of the apo E genotyping kit on the Light-Cycler. Clin Chem 46:722–724.
   PubMed Web of Science ®Google Scholar
• Nevajda B, Havelka-Mestrovic A, Bilic M, Nevajda AP, Romic D, Vuletic V, et al. 2013. Prevalence of the metabolic syndrome in the old institutionalized people in Zagreb, Croatia. Collegium Antropol 37:203–206.
   PubMedGoogle Scholar
• Phillips CM. 2013. Nutrigenetics and metabolic disease: current status and implications for personalised nutrition. Nutrients 5:32–57.
   PubMed Web of Science ®Google Scholar
• Povel CM, Boer JMA, Reiling E, Feskens EJM. 2011. Genetic variants and the metabolic syndrome: a systematic review. Obes Rev 12:952–967.
   PubMed Web of Science ®Google Scholar
• Sertic J, Juricic L, Ljubic H, Bozina T, Lovric J, Markeljevic J, et al. 2009. Variants of ESR1, APOE, LPL and IL-6 loci in young healthy subjects: association with lipid status and obesity. BMC Res Notes 2:203.
   PubMedGoogle Scholar
• Sima A, Lordan A, Stancu C. 2007. Apolipoprotein E polymorphism - a risk factor for metabolic syndrome. Clin Chem Lab Med 45:1149–1153.
   PubMed Web of Science ®Google Scholar
• Stojanovic S, Ilic MD, Ilic S, Petrovic D, Djukic S. 2015. The significance of adiponectin as a biomarker in metabolic syndrome and/or coronary artery disease. Vojnosanit Pregl 72:779–784.
   PubMed Web of Science ®Google Scholar
• Talmud PJ. 2007. Gene-environment interaction and its impact on coronary heart disease risk. Nutr Metab Cardiovas 17:148–152.
   Web of Science ®Google Scholar
• Thaman RaAG. 2013. Metabolic Syndrome: definition and pathophysiology - the discussion goes on! J Physiol Pharmacol Adv 3:48–56.
   Google Scholar
• Tortosa A, Bes-Rastrollo M, Sanchez-Villegas A, Basterra-Gortari FJ, Nunez-Cordoba JM, Martinez-Gonzalez MA. 2007. Mediterranean diet inversely associated with the incidence of metabolic syndrome: The SUN prospective cohort. Diabetes Care 30:2957–2959.
   PubMed Web of Science ®Google Scholar
• Vucinic N, Djan I, Stokic E, Bozin B, Obreht D, Stankov K, Djan M. 2014. Different associations of apoE gene polymorphism with metabolic syndrome in the Vojvodina Province (Serbia). Mol Biol Rep 41:5221–5227.
   PubMed Web of Science ®Google Scholar
• Wei LK, Menon S, Griffiths LR, Gan SH. 2015. Signaling pathway genes for blood pressure, folate and cholesterol levels among hypertensives: an epistasis analysis. J Hum Hypertens 29:99–104.
   PubMed Web of Science ®Google Scholar
• Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA, Balis UJ. 1997. The LightCycler(TM) a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 22:176–181.
   PubMed Web of Science ®Google Scholar
• Yang WJ, Kelly T, He J. 2007. Genetic epidemiology of obesity. Epidemiol Rev 29:49–61.
   PubMed Web of Science ®Google Scholar
• Zarkesh M, Daneshpour MS, Faam B, Hedayati M, Azizi F. 2012. Is there any association of apolipoprotein E gene polymorphism with obesity status and lipid profiles? Tehran Lipid and Glucose Study (TLGS). Gene 509:282–285.
   PubMed Web of Science ®Google Scholar
• Zeljko HM, Skaric-Juric T, Narancic NS, Tomas Z, Baresic A, Salihovic MP, et al. 2011. E2 allele of the apolipoprotein E gene polymorphism is predictive for obesity status in Roma minority population of Croatia. Lipids Health Dis 10: 9.
   PubMedGoogle Scholar